NCNP-03

· NS Pharma, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NCNP-03, covering 2026-04-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: NS-050/NCNP-03 in Boys With DMD (Meteor50) [Phase 1, Phase 2]